M S Lui, R C Jackson, G Weber. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » 3-Deazauridine/administration & dosage3-Deazauridine/pharmacology3-Deazauridine/therapeutic useAnimalsAntibiotics, Antineoplastic/administration & dosageAntibiotics, Antineoplastic/pharmacologyAntibiotics, Antineoplastic/therapeutic useDrug Therapy, CombinationGalactosamine/administration & dosageGalactosamine/pharmacologyGalactosamine/therapeutic useIn Vitro TechniquesLiver Neoplasms, Experimental/drug therapyLiver Neoplasms, Experimental/metabolismMaleOrotic Acid/pharmacologyRatsRibonucleosides/administration & dosageRibonucleosides/pharmacologyRibonucleosides/therapeutic useRibonucleotides/metabolismUridine/analogs & derivativesUridine/pharmacology
Substances： See more » Antibiotics, AntineoplasticRibonucleosidesRibonucleotides3-DeazauridineOrotic AcidGalactosamineUridine
Year: 1979 PMID： 444276 DOI： 10.1016/0006-2952(79)90327-7
Source DB: PubMed Journal: Biochem Pharmacol ISSN： 0006-2952 Impact factor: 5.858